In confirmation of the mentioned effect, subjecting a STZ-induced diabetic cardiomyopathy mice model to a 10-week swimming program unregulated the miR-133, improved contractile properties and reduced an extracellular matrix (ECM) regulatory protein; metallopeptidase-9 (MMP9) (6). Here, MMP9 is linked to diabetic cardiomyopathy.